within Pharmacolibrary.Drugs.ATC.G;

model G03DB08
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.91,
    Cl             = 5.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.046,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.043333333333333335,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.132,
    k12             = 7.8,
    k21             = 7.8
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03DB08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dienogest is a synthetic progestogen (progestin) used primarily for the treatment of endometriosis and as a component in contraceptive preparations. It is approved and currently used in several countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult women after oral administration of dienogest, 2 mg daily dosing.</p><h4>References</h4><ol><li><p>Pérez-Campos, EF (2010). Ethinylestradiol/dienogest in oral contraception. <i>Drugs</i> 70(6) 681–689. DOI:<a href=\"https://doi.org/10.2165/11536320-000000000-00000\">10.2165/11536320-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20394455/\">https://pubmed.ncbi.nlm.nih.gov/20394455</a></p></li><li><p>Stanczyk, FZ, et al., &amp; Archer, DF (2024). Comparison of estrogenic components used for hormonal contraception. <i>Contraception</i> 130 110310–None. DOI:<a href=\"https://doi.org/10.1016/j.contraception.2023.110310\">10.1016/j.contraception.2023.110310</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37863464/\">https://pubmed.ncbi.nlm.nih.gov/37863464</a></p></li><li><p>Whalen, KL, &amp; Rose, R (2011). Estradiol valerate/dienogest: a novel oral contraceptive. <i>The Annals of pharmacotherapy</i> 45(10) 1256–1261. DOI:<a href=\"https://doi.org/10.1345/aph.1Q216\">10.1345/aph.1Q216</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21917554/\">https://pubmed.ncbi.nlm.nih.gov/21917554</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03DB08;
